Bone density decreased – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 11:28:23 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Bone density decreased – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Impact of LF111 and Drospirenone on Bone Health in Adolescent and Adult Women Using Oral Contraceptives https://clinicaltrials.eu/trial/study-on-the-impact-of-lf111-and-drospirenone-on-bone-health-in-adolescent-and-adult-women-using-oral-contraceptives/ Wed, 29 Apr 2026 15:05:47 +0000 https://clinicaltrials.eu/trial/study-on-the-impact-of-lf111-and-drospirenone-on-bone-health-in-adolescent-and-adult-women-using-oral-contraceptives/ This clinical trial is focused on studying the effects of hormonal contraceptives on bone health in women. The study involves the use of two types of chewable tablets: one containing the active ingredient drospirenone and another with a code name LF111. These medications are being compared to non-hormonal contraceptive methods to see how they affect bone mineral density, which is a measure of bone strength, in the lower back area over a period of 12 months.

The purpose of the study is to evaluate the impact of these hormonal contraceptives on bone health in adolescent and adult women. Participants will be divided into groups, with some taking the drospirenone or LF111 tablets, while others will use non-hormonal methods. The study will last for about a year, during which participants will undergo regular check-ups to monitor changes in their bone health and other health indicators like body weight and hormone levels.

Throughout the study, participants will be observed for any changes in their bone mineral density, as well as any side effects or changes in routine health measures. This research aims to provide valuable information on how hormonal contraceptives might affect bone health, helping to guide future healthcare decisions for women using these methods.

]]>